SSCI Offers Benchmarks As Gatekeepers For Supplements To Reach Retail Shelves
Executive Summary
FDA’s GMP final rule set uniform standards to ensure quality throughout manufacturing, packaging, labeling and holding of supplements, but Supplement Safety and Compliance Initiative says manufacturing practices continue to vary widely across the industry and the agency cannot inspect every facility. “FDA can’t solve all our problems. I don’t know if FDA knows the number of facilities it needs to inspect to ensure consumer confidence," says Daniel Fabricant, president of SSCI member NPA.
You may also be interested in...
FDA Slacking In NDI Notification Enforcement; COVID-19 'Is Not An Excuse’ – NPA
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.
FDA Dietary Supplement Programs Research, Strategy Official Moves To NPA
Sibyl Swift is responsible for developing and implementing NPA's educational, regulatory and compliance programs such as SSCI and the NPA Natural Standard. She also will assist members with claim reviews, substantiation and NDI notification policy.
Supplement Firm Fails GMP Inspection Four Months After Third-Party Certification
GMP warning to Nutra Solutions USA reflects not only that manufacturers and other supplement firms are responsible to maintain compliance at their facilities, but also third-party inspectors should be responsible for their certifications, say industry stakeholders.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: